Horizon 2020: Innovative Medicines Initiative - Development of therapeutics and diagnostics combatting coronaviruses infections - IMI2-2020-21-01
STANZIAMENTO
€ 45.000.000
SCADENZA
31/03/2020
The European Commission funds through Horizon 2020, the EU research and innovation programme, up to €45 million of the Innovative Medicines Initiative (IMI) fast track call for research proposals in response to the COVID-19 outbreak. A commitment of a similar scale is expected from the pharmaceutical industry so that the total investment could reach up to €90 million.
The scope of the Call is broad and proposals must address one of the following objectives:
- development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak;
- development of therapeutics to address the current and/or future coronavirus outbrea